AI Article Synopsis
- Radiotherapy (RT) is commonly used for both malignant tumors and certain benign conditions, with low or intermediate doses being the focus of recent studies.
- The review discusses the indications for low dose irradiation (LD-RT), including total dosage, different treatment fractionations, and targeted patient groups.
- Additionally, it provides an analysis of potential secondary effects, aiming to encourage radiation oncologists and other physicians to consider LD-RT for their patients.
Article Abstract
Radiotherapy (RT) has always been a mainstay for malignant tumors therapy, but it is also used for benign pathology. The application of low or intermediate doses of RT has been widely studied. This topic was presented and discussed in the last XX GOCO (Grup Oncològic Català-Occità) meeting. The aim of this article is to review the indications of low dose irradiation (LD-RT), total dose and different fractionations, the public to whom it can be directed, and to offer an analysis about secondary effects. We believe it can be useful not only for radiation oncologists, but for other physicians to consider this option for future patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049618 | PMC |
| http://dx.doi.org/10.1016/j.rpor.2020.02.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!